Johnson & Johnson

Page 3 of 18

a person uses Johnson & Johnson baby powder.
Finance

Johnson & Johnson offers $8.9 billion settlement to roughly 60,000 people who claim its talc products gave them cancer

By Jef Feeley, Steven Church and Bloomberg
April 5, 2023
Impella patient
Health

Johnson & Johnson is paying $17.3 billion to buy a company that helps your heart pump blood

By Madison Muller and Bloomberg
November 1, 2022
Chief diversity officers on the key to leveling the corporate playing field
Conferences

Chief diversity officers on the key to leveling the corporate playing field

By
September 16, 2022
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
Finance

The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021

By
August 15, 2022
Johnson baby powder is displayed on a table.
Health

Johnson & Johnson to stop selling talc-based baby powder as cancer lawsuits pile on

By Riley Griffin, Jef Feeley and Bloomberg
August 11, 2022
Alex Gorsky, chief executive officer of Johnson & Johnson, speaks during an event in the Eisenhower Executive Office Building in Washington, D.C., U.S., on Wednesday, March 10, 2021.
Newsletters

The wisdom of J&J’s Alex Gorsky

By David Meyer and Alan Murray
June 10, 2022
Musk claims S&P ‘lost their integrity’ after Tesla gets booted from sustainability index while Exxon is included
Finance

Musk claims S&P ‘lost their integrity’ after Tesla gets booted from sustainability index while Exxon is included

By
May 18, 2022
A nurse prepares a pediatric dose of the Pfizer-BioNTech Covid-19 vaccine.
Health

FDA restricts Johnson & Johnson’s COVID-19 vaccine to people 18 and older due to blood clot risk

By Matthew Perrone, Lauran Neergaard and The Associated Press
May 5, 2022
Albert Bourla, chairman and chief executive officer of Pfizer Inc., speaks during South By Southwest.
Health

The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic

By Sy Mukherjee and IDEA Pharma
April 20, 2022
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
Health

The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant

By
March 15, 2022
a man and a woman looking at an iPhone in a store
Leadership

Apple, Walt Disney, and UnitedHealth have this in common: Their business rivals give them ultra-high performance scores

By Matthew Heimer and Scott DeCarlo
February 2, 2022
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
Health

With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones

By Erika Fry and Nicolas Rapp
January 5, 2022
A Johnson & Johnson booster reduces Omicron hospitalizations by up to 85%, says a new South African study
Health

A Johnson & Johnson booster reduces Omicron hospitalizations by up to 85%, says a new South African study

By Michelle Fay Cortez and Bloomberg
December 30, 2021
A health care worker prepares a Moderna booster vaccine dose.
Health

Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries

By
December 27, 2021
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
Health

J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study

By
December 17, 2021

Most Popular